Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Plasma tau
Plasma β-Amyloid 42/40 (Aβ42/Aβ40)
+3 more
Locations
1
Sweden
Skåne University Hospital
Malmo, Sweden
Start Date
April 1, 2022
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
April 6, 2026
NCT07545473
NCT07531732
NCT07290387
NCT07101380
NCT06657768
NCT07220668
Lead Sponsor
Skane University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions